TRPM8 and cancer: TRPM8 was linked to the effect of other chemotherapeutics, including Lapatinib, Erlotinib, Afatinib, and Dabrafenib, which are approved for treating diverse cancers (Pan et al., 2022; Zhang et al., 2022).